Log In
Contact Us
National Plans
Dynamic Charts

Longevity Industry Dashboards

Search For...

Longevity Governance


Introduction & Big Data Comparative Analysis Framework

Life expectancy is increasing all around the world. While there have been obvious fluctuations in the dynamics of this statistically measured demographic indicator, life expectancy at birth overall has been steadily increasing for many years. It has more than doubled in the last two centuries.


This increase was previously driven by reductions in infant mortality. But since around the 1950s, the main factor of steady increase has been reductions in mortality at older ages. This has contributed to the ageing of the population and critical changes in age distribution, which can be described with old-age dependency ratio.


The major problem with merely increasing life expectancy is that it also increases morbidity because people live long enough to get more age-related disease, disability, dementia, and dysfunction. Many serious diseases have increased prevalence with age, including cancer, heart disease, stroke, respiratory disease, kidney disease, dementia, arthritis, and osteoporosis.


Consequently, it is unclear why countries are investing so much money in research focused on reducing death rates in the elderly, if the consequence is advancing ageing, that can be described as the increase in disability years, plus pension, and social and medical costs, in an unsustainable way.


Ageing is caused by many different processes, that is why healthy longevity goes far beyond demographic characteristics and medical research problems on how to increase the quantity of life.


This paper seeks to identify which health system characteristics, socio-economic factors, and environmental conditions are likely to increase health-adjusted life expectancy and improve the quality of life.


The analysis is based on the +200 parameters that define healthy longevity across the chosen 50 countries.


200+ Analysed Parameters per country